vs
FrontView REIT, Inc.（FVR）与Valneva SE（VALN）财务数据对比。点击上方公司名可切换其他公司
Valneva SE的季度营收约是FrontView REIT, Inc.的2.0倍（$36.2M vs $18.2M），FrontView REIT, Inc.净利率更高（2.2% vs -54.1%，领先56.3%）
Valneva SE是一家专注于 specialty 疫苗领域的企业，注册地位于法国圣埃尔布兰，主营业务是传染病疫苗的研发、生产与商业化销售。公司在苏格兰利文斯顿、瑞典索尔纳、奥地利维也纳设有生产基地，另在法国、加拿大、美国设有办公机构。
FVR vs VALN — 直观对比
营收规模更大
VALN
是对方的2.0倍
$18.2M
净利率更高
FVR
高出56.3%
-54.1%
损益表 — Q1 FY2026 vs Q1 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $18.2M | $36.2M |
| 净利润 | $400.0K | $-19.6M |
| 毛利率 | — | 38.9% |
| 营业利润率 | 24.9% | -49.5% |
| 净利率 | 2.2% | -54.1% |
| 营收同比 | 12.0% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVRVALN
| Q1 26 | $18.2M | — | ||
| Q4 25 | $16.5M | — | ||
| Q3 25 | $16.8M | — | ||
| Q2 25 | $17.6M | — | ||
| Q1 25 | $16.2M | — | ||
| Q3 24 | $14.5M | — | ||
| Q1 23 | — | $36.2M | ||
| Q2 22 | — | $93.2M |
净利润FVRVALN
| Q1 26 | $400.0K | — | ||
| Q4 25 | $-4.1M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $-2.9M | — | ||
| Q1 25 | $-833.0K | — | ||
| Q3 24 | $-2.4M | — | ||
| Q1 23 | — | $-19.6M | ||
| Q2 22 | — | — |
毛利率FVRVALN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | 38.9% | ||
| Q2 22 | — | — |
营业利润率FVRVALN
| Q1 26 | 24.9% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | -49.5% | ||
| Q2 22 | — | -161.3% |
净利率FVRVALN
| Q1 26 | 2.2% | — | ||
| Q4 25 | -24.9% | — | ||
| Q3 25 | 23.9% | — | ||
| Q2 25 | -16.5% | — | ||
| Q1 25 | -5.1% | — | ||
| Q3 24 | -16.7% | — | ||
| Q1 23 | — | -54.1% | ||
| Q2 22 | — | — |
每股收益（稀释后）FVRVALN
| Q1 26 | — | — | ||
| Q4 25 | $-0.19 | — | ||
| Q3 25 | $0.19 | — | ||
| Q2 25 | $-0.16 | — | ||
| Q1 25 | $-0.06 | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.3M | $274.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $514.2M | $221.2M |
| 总资产 | $869.8M | $637.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FVRVALN
| Q1 26 | $9.3M | — | ||
| Q4 25 | $13.5M | — | ||
| Q3 25 | $19.6M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $3.3M | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | $274.8M | ||
| Q2 22 | — | $363.1M |
总债务FVRVALN
| Q1 26 | — | — | ||
| Q4 25 | $314.3M | — | ||
| Q3 25 | $307.1M | — | ||
| Q2 25 | $316.9M | — | ||
| Q1 25 | $310.2M | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
股东权益FVRVALN
| Q1 26 | $514.2M | — | ||
| Q4 25 | $391.2M | — | ||
| Q3 25 | $385.2M | — | ||
| Q2 25 | $369.9M | — | ||
| Q1 25 | $324.7M | — | ||
| Q3 24 | $1.0K | — | ||
| Q1 23 | — | $221.2M | ||
| Q2 22 | — | $100.7M |
总资产FVRVALN
| Q1 26 | $869.8M | — | ||
| Q4 25 | $854.4M | — | ||
| Q3 25 | $846.8M | — | ||
| Q2 25 | $856.5M | — | ||
| Q1 25 | $860.8M | — | ||
| Q3 24 | $1.0K | — | ||
| Q1 23 | — | $637.2M | ||
| Q2 22 | — | $783.1M |
负债/权益比FVRVALN
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | 0.96× | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FVRVALN
| Q1 26 | — | — | ||
| Q4 25 | $42.1M | — | ||
| Q3 25 | $8.3M | — | ||
| Q2 25 | $9.3M | — | ||
| Q1 25 | $8.1M | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | $-26.3M | ||
| Q2 22 | — | — |
现金转化率FVRVALN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
